The transaction includes all of Diamond V’s business — the human health business, Embria Health Sciences, and its branded product EpiCor which is a specialty ingredient that supports immune system health. The company’s headquarters will remain in Cedar Rapids, and the Diamond V brand will be the basis for future investments in natural solutions that enhance the safety of animal food production.
“This acquisition strengthens Cargill’s and Diamond V’s shared vision to be a leader in creating new solutions for evolving consumer preferences for sustainable and wholesome food production,” David MacLennan, chairman and CEO of Cargill, said in a statement. “Our combined businesses will accelerate growth, build industry-leading capabilities and natural solutions for animal health and food safety, and help fulfill Cargill’s purpose to nourish the world in a safe, responsible and sustainable way.”
The acquisition of Diamond V follows Cargill’s recent investment in Delacon, a leading producer of plant-based phytogenic additive. Both transactions give Cargill a $20 billion foothold in the global animal feed additives market in addition to competitive technical, regulatory and R&D capabilities and go-to-market strength in approximately 70 countries worldwide.
“Diamond V is a tremendous company with deep scientific expertise and a highly respected global brand,” said Chuck Warta, president of Cargill’s premix and nutrition business. “Adding Diamond V’s leading talent and technology as well as its applications for sustainable protein production, will enable us to deliver improved profitability and performance for our customers. Together, Cargill and Diamond V will accelerate the pace of innovation and drive strategic, long-term growth.”